Department of Pediatrics

December 13, 2012

CDC selects VU to lead national adverse vaccine event reviews

Vanderbilt University Medical Center has been selected by the Centers for Disease Control and Prevention (CDC), to lead a consortium of top national experts in vaccine safety in performing timely reviews of adverse vaccine events.

By VUMC News and Communications
syringe
November 12, 2012

UNC, Vanderbilt discover a new live vaccine approach for SARS and novel coronaviruses

Collaborating researchers at the University of North Carolina and Vanderbilt University have found that accelerating the rate of mutations in the coronavirus responsible for deadly severe acute respiratory syndrome (SARS) cripples the virus’s ability to cause disease in animals.

By VUMC News and Communications
November 8, 2012

Kidney Transplantation Program celebrates 50 years

There are many reasons why David Shaffer, M.D., surgical director of the Kidney Transplantation Program at Vanderbilt University Medical Center, loves his job.

By Jessica Pasley
October 25, 2012

Project targets sickle cell disease in Nigeria

Researchers from the Monroe Carell Jr. Children’s Hospital at Vanderbilt and Aminu Kano Teaching Hospital in Kano, Nigeria, will work on a collaborative project to study a sickle cell disease treatment for children in Nigeria.

By Christina Echegaray
October 18, 2012

Gene regulation found to play role in pulmonary hypertension

New findings from Vanderbilt researchers may explain why only some individuals who have inherited mutations that increase risk for pulmonary hypertension actually develop the disease.

By Leigh MacMillan
October 11, 2012

Pneumonia vaccine for children to be tested in older adults

Vanderbilt is taking part in a national study to test in older adults the use of a vaccine designed to protect children against a common cause of pneumonia.

By VUMC News and Communications
September 24, 2012

Little evidence supports medical treatment options for adolescents with autism

Despite studies that show that many adolescents and young adults with autism spectrum disorders are being prescribed medications, there is almost no evidence to show whether these medications are helpful in this population.
By VUMC News and Communications
August 30, 2012

Diabetes can’t hold back Little League champion

By Christina Echegaray
August 27, 2012

Little evidence supports autism treatment options in adolescents

There is insufficient evidence to support findings, good or bad, for therapies currently used in adolescents and young adults with autism.
By VUMC News and Communications
July 31, 2012

National type I diabetes prevention trial now an option for younger children

A type I diabetes prevention study that is part of the TrialNet program at Vanderbilt is now enrolling children as young as 8 years old.
By Craig Boerner
July 30, 2012

Doctors see rise in tick-borne illnesses and other insect-related infections

By VUMC News and Communications
April 19, 2012

MRSA in pregnancy may be less dangerous than previously thought

Vanderbilt pediatric infectious disease researchers studying antibiotic-resistant staph say fears that mothers carrying the germ may set their newborns up for infection are unfounded.
By VUMC News and Communications
April 6, 2012

Plant compound quells inflammation

Berberine, an herbal remedy for diarrhea and intestinal parasites, may be an effective treatment for gastrointestinal inflammatory diseases.
By Leigh MacMillan
1 … 49 50 51 52 53 … 56